Literature DB >> 999943

Modulation of membrane drug permeability in Chinese hamster ovary cells.

S A Carlsen, J E Till, V Ling.   

Abstract

The kinetics of colchicine uptake into Chinese hamster ovary cells have been investigated and found to be consistent with an unmediated diffusion mode. A variety of compounds such as local anesthetics and non-ionic detergents as well as drugs such as vinblastine, vincristine, daunomycin and actinomycin D potentiate the rate of colchicine uptake into these cells and into colchicine resistant mutants. In all cases, higher concentrations of these compounds were required to stimulate colchicine uptake in the colchicine resistant mutants than in the cells of the parental line. This stimulation was observed also in the uptake of puromycin, a structurally and functionally different drug. These stimulatory agents did not, however, cause the cells to become nonspecifically leaky since the uptake of 2-deoxy-D-glucose was unaffected. In addition, the activation energy of colchicine uptake was unaltered in the presence of stimulating agents, implying that they were not causing colchicine to enter the cells via a different mechanism. The results are compatible with the view that these compounds are membrane-active, and are able to stimulate an increased rate of unmediated diffusion of colchicine into the cells. It appears that a mechanism for the regulation of passive permeability is modified in the resistant mutants.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 999943     DOI: 10.1016/0005-2736(76)90059-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

1.  Overexpression and amplification of five genes in a multidrug-resistant Chinese hamster ovary cell line.

Authors:  A M Van der Bliek; T Van der Velde-Koerts; V Ling; P Borst
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

2.  Expression of a multidrug-resistance gene in human tumors and tissues.

Authors:  A T Fojo; K Ueda; D J Slamon; D G Poplack; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

3.  Intracellular pH and the control of multidrug resistance.

Authors:  S Simon; D Roy; M Schindler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

4.  Intravesical chemotherapy: combination with Tween 80 increases cytotoxicity in vitro.

Authors:  C N Parris; J R Masters; M C Walker; B Newman; P Riddle; P English
Journal:  Urol Res       Date:  1987

5.  Uptake of colchicine, a microtubular system disrupting agent, by isolated rat hepatocytes.

Authors:  K Wierzba; Y Sugiyama; K Okudaira; T Iga; M Hanano
Journal:  Pharm Res       Date:  1989-03       Impact factor: 4.200

6.  Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells.

Authors:  A T Fojo; J Whang-Peng; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

7.  Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer.

Authors:  Joseph A Ludwig; Gergely Szakács; Scott E Martin; Benjamin F Chu; Carol Cardarelli; Zuben E Sauna; Natasha J Caplen; Henry M Fales; Suresh V Ambudkar; John N Weinstein; Michael M Gottesman
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

8.  DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression.

Authors:  P G Debenham; N Kartner; L Siminovitch; J R Riordan; V Ling
Journal:  Mol Cell Biol       Date:  1982-08       Impact factor: 4.272

Review 9.  Is resistance useless? Multidrug resistance and collateral sensitivity.

Authors:  Matthew D Hall; Misty D Handley; Michael M Gottesman
Journal:  Trends Pharmacol Sci       Date:  2009-09-15       Impact factor: 14.819

10.  Mechanisms of action of intravesical treatment. Effect on the ABH surface antigens of urothelial cells.

Authors:  G Jakse; F Hofstädter
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.